Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(66.7%)
N/A
1(33.3%)
3Total
Phase 4(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT07416721Not ApplicableNot Yet Recruiting

Cooling of the Knee After Total Knee Arthroplasty

Role: lead

NCT07405840Phase 4Active Not Recruiting

Application of Autologous Stem Cells From Adipose Tissue in the Regeneration of Knee Joint Cartilage

Role: lead

NCT07387575Enrolling By Invitation

Screening in Relatives With Elevated Risk for Unruptured Intracranial Aneurysms

Role: collaborator

NCT06838585Completed

Intra-Abdominal Sepsis and Relationship Between Cumulative Fluid Balance and Serum Sodium and Chloride Levels and In-Hospital Mortality

Role: lead

NCT06030791Unknown

BTB Graft Harvest and Donor Site Morbidity After ACL Reconstruction

Role: lead

NCT05390294Completed

Survival With Patients Treated With Salivary Gland Cancer

Role: lead

NCT04865003Completed

Prognostic Factors for Descending Necrotizing Mediastinitis Development in Deep Space Neck Infections

Role: lead

NCT03825133Phase 4Completed

The Comparison of Knee Osteoarthritis Treatment With Bone Marrow Aspirate Concentrate , Leukocyte Rich Platelet Rich Plasma and Hyaluronic Acid

Role: lead

All 8 trials loaded